Concepedia

Common risk factors for the development of anti tuberculosis treatment induced hepatotoxicity.

Munir Ahmad Abbasi, Naseer Ahmed, Amir Suleman, Haidar Zaman, Sumbal Tariq, Syed Abbas Anwar, Nisar Khan

PubMed · 2015 · 11 citations · 11 references

Abstract

The study showed that the risk of development of drug-induced hepatotoxicity following treatment with first line anti-tuberculosis treatment increased with the age of the patient.

References

11

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

Daphne Yee, Chantal Valiquette, Marthe Pelletier et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 833 citations

, , +15

Isoniazid-Associated Hepatitis in 114 Patients

Martin Black, Jerry R. Mitchell, Hyman J. Zimmerman et al. · Gastroenterology · 1975 · 373 citations

, , +3

Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.

Rohit Singla, Surendra K. Sharma, Alladi Mohan et al. · PubMed · 2010 · 126 citations

Risk factors for hepatotoxicity associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection: experience from three public health tuberculosis clinics.

A M Lee, J Z Mennone, R. C. Jones et al. · PubMed · 2002 · 77 citations

Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs

Julián G. Chamorro, Jorge Castagnino, Rosa Musella et al. · Journal of Gastroenterology and Hepatology · 2012 · 66 citations

, , +18